Similar articles for PMID: 19487545

Year	Number of Results
1991	2
1992	2
1993	4
1994	4
1995	3
1996	3
1997	2
1998	7
2000	2
2001	6
2002	3
2003	1
2004	4
2005	3
2006	6
2007	2
2008	3
2009	7
2010	4
2011	1
2013	2
2014	3
2015	2
2016	3
2017	3
2018	10
2019	1
2020	3
2022	1
2024	0

1

Gene expression analysis of HCT116 colon tumor-derived cells treated with the polyamine analog PG-11047.

Ignatenko NA, Yerushalmi HF, Pandey R, Kachel KL, Stringer DE, Marton LJ, Gerner EW. Ignatenko NA, et al. Cancer Genomics Proteomics. 2009 May-Jun;6(3):161-75. Cancer Genomics Proteomics. 2009. PMID: 19487545 Free PMC article.

2

Pharmacogenomics of the polyamine analog 3,8,13,18-tetraaza-10,11-[(E)-1,2-cyclopropyl]eicosane tetrahydrochloride, CGC-11093, in the colon adenocarcinoma cell line HCT1161.

Ignatenko NA, Yerushalmi HF, Watts GS, Futscher BW, Stringer DE, Marton LJ, Gerner EW. Ignatenko NA, et al. Technol Cancer Res Treat. 2006 Dec;5(6):553-64. doi: 10.1177/153303460600500602. Technol Cancer Res Treat. 2006. PMID: 17121431 Free article.

3

Antitumor activity of the polyamine analog N(1), N(11)-diethylnorspermine against human prostate carcinoma cells.

Schipper RG, Deli G, Deloyer P, Lange WP, Schalken JA, Verhofstad AA. Schipper RG, et al. Prostate. 2000 Sep 1;44(4):313-21. doi: 10.1002/1097-0045(20000901)44:4<313::aid-pros8>3.0.co;2-d. Prostate. 2000. PMID: 10951496

4

Inhibition of autophagy enhances DENSpm-induced apoptosis in human colon cancer cells in a p53 independent manner.

Gurkan AC, Arisan ED, Yerlikaya PO, Ilhan H, Unsal NP. Gurkan AC, et al. Cell Oncol (Dordr). 2018 Jun;41(3):297-317. doi: 10.1007/s13402-017-0369-x. Epub 2018 Feb 28. Cell Oncol (Dordr). 2018. PMID: 29492901

5

Biochemical evaluation of the anticancer potential of the polyamine-based nanocarrier Nano11047.

Murray-Stewart T, Ferrari E, Xie Y, Yu F, Marton LJ, Oupicky D, Casero RA Jr. Murray-Stewart T, et al. PLoS One. 2017 Apr 19;12(4):e0175917. doi: 10.1371/journal.pone.0175917. eCollection 2017. PLoS One. 2017. PMID: 28423064 Free PMC article.

6

The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines.

Pledgie-Tracy A, Billam M, Hacker A, Sobolewski MD, Woster PM, Zhang Z, Casero RA, Davidson NE. Pledgie-Tracy A, et al. Cancer Chemother Pharmacol. 2010 May;65(6):1067-81. doi: 10.1007/s00280-009-1112-8. Epub 2009 Aug 30. Cancer Chemother Pharmacol. 2010. PMID: 19727732 Free PMC article.

7

A systems analysis of the chemosensitivity of breast cancer cells to the polyamine analogue PG-11047.

Kuo WL, Das D, Ziyad S, Bhattacharya S, Gibb WJ, Heiser LM, Sadanandam A, Fontenay GV, Hu Z, Wang NJ, Bayani N, Feiler HS, Neve RM, Wyrobek AJ, Spellman PT, Marton LJ, Gray JW. Kuo WL, et al. BMC Med. 2009 Dec 14;7:77. doi: 10.1186/1741-7015-7-77. BMC Med. 2009. PMID: 20003408 Free PMC article.

8

Conformationally restricted analogues of 1N,14N-bisethylhomospermine (BE-4-4-4): synthesis and growth inhibitory effects on human prostate cancer cells.

Valasinas A, Sarkar A, Reddy VK, Marton LJ, Basu HS, Frydman B. Valasinas A, et al. J Med Chem. 2001 Feb 1;44(3):390-403. doi: 10.1021/jm000309t. J Med Chem. 2001. PMID: 11462979

9

Combination effects of platinum drugs and N1, N11 diethylnorspermine on spermidine/spermine N1-acetyltransferase, polyamines and growth inhibition in A2780 human ovarian carcinoma cells and their oxaliplatin and cisplatin-resistant variants.

Tummala R, Diegelman P, Hector S, Kramer DL, Clark K, Zagst P, Fetterly G, Porter CW, Pendyala L. Tummala R, et al. Cancer Chemother Pharmacol. 2011 Feb;67(2):401-14. doi: 10.1007/s00280-010-1334-9. Epub 2010 May 5. Cancer Chemother Pharmacol. 2011. PMID: 20443003 Free PMC article.

10

The role of spermidine/spermine N1-acetyltransferase in determining response to chemotherapeutic agents in colorectal cancer cells.

Allen WL, McLean EG, Boyer J, McCulla A, Wilson PM, Coyle V, Longley DB, Casero RA Jr, Johnston PG. Allen WL, et al. Mol Cancer Ther. 2007 Jan;6(1):128-37. doi: 10.1158/1535-7163.MCT-06-0303. Mol Cancer Ther. 2007. PMID: 17237273

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

91 results

Results by year